Journal: Thoracic cancer

Article Title: Management of malignant pleural mesothelioma.

PMID/MRN: 27755778

Publication Date: 2010-Jul-19

Abstract:

Malignant pleural mesothelioma is a rare neoplasm arising from the surface serosal cells of the pleural cavity. More than 80% of cases of malignant pleural mesothelioma have been attributed to asbestos exposure. In its natural course median survival is 4 to 12 months. If untreated most of patients die due to local complications of the disease. Surgery improves local control but is not sufficient as a single treatment modality. The recommended treatment strategy for a select group of patients is multimodal therapy that includes surgery, radiotherapy and chemotherapy. © Tianjin Lung Cancer Institute and Blackwell Publishing Asia Pty. Ltd.